Jacob S Young, MD, Anthony T Lee, MD, PhD, Edward F Chang, MD
doi : 10.1093/neuros/nyaa436
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 331–342
Since the early descriptions of language function based on observations of patients with language deficits by Broca and Wernicke, neurosurgeons have been focused on characterizing the anatomic regions necessary for language perception and production, and preserving these structures during surgery to minimize patient deficits post operatively. In this supplementary issue on awake intraoperative mapping, we review language processing across multiple domains, highlighting key advances in direct electrical stimulation of different cortical and subcortical regions involved in naming, repetition, reading, writing, and syntax. We then discuss different intraoperative tasks for assessing the function of a given area and avoiding injury to critical, eloquent regions.
Saber Tadros, MD, Aleksei Kondrashov, MD, Sriya Namagiri, BA, Ashis Chowdhury, BHMS, Yeshavanth Kumar Banasavadi-Siddegowda, PhD, Abhik Ray-Chaudhury, MD
doi : 10.1093/neuros/nyab019
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 343–363
Hereditary cancer predisposition syndromes (HCS) become more recognizable as the knowledge about them expands, and genetic testing becomes more affordable. In this review, we discussed the known HCS that predispose to central and peripheral nervous system tumors. Different genetic phenomena were highlighted, and the important cellular biological alterations were summarized. Genetic mosaicism and germline mutations are features of HCS, and recently, they were described in normal population and as modifiers for the genetic landscape of sporadic tumors. Description of the tumors arising in these conditions was augmented by representative cases explaining the main pathological findings. Clinical spectrum of the syndromes and diagnostic criteria were tabled to outline their role in defining these disorders. Interestingly, precision medicine has found its way to help these groups of patients by offering targeted preventive measures. Understanding the signaling pathway alteration of mammalian target of rapamycin (mTOR) in tuberous sclerosis helped introducing mTOR inhibitors as a prophylactic treatment in these patients. More research to define the germline genetic alterations and resulting cellular signaling perturbations is needed for effective risk-reducing interventions beyond prophylactic surgeries.
Michael J Cruz, BA, Edwin Nieblas-Bedolla, MPH, Christopher C Young, MD, PhD, Abdullah H Feroze, MD, John R Williams, MD, Richard G Ellenbogen, MD, Michael R Levitt, MD
doi : 10.1093/neuros/nyab185
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 364–371
Telemedicine has received increased attention in recent years as a potential solution to expand clinical capability and patient access to care in many fields, including neurosurgery. Although patient and physician attitudes are rapidly shifting toward greater telemedicine use in light of the COVID-19 pandemic, there remains uncertainty about telemedicine's regulatory future. Despite growing evidence of telemedicine's utility, there remain a number of significant medicolegal barriers to its mass adoption and wider implementation. Herein, we examine recent progress in state and federal regulations in the United States governing telemedicine's implementation in quality of care, finance and billing, privacy and confidentiality, risk and liability, and geography and interstate licensure, with special attention to how these concern teleneurosurgical practice. We also review contemporary topics germane to the future of teleneurosurgery, including the continued expansion of reciprocity in interstate licensure, expanded coverage for homecare services for chronic conditions, expansion of Center for Medicare and Medicaid Services reimbursements, and protections of store-and-forward technologies. Additionally, we discuss recent successes in teleneurosurgery, stroke care, and rehabilitation as models for teleneurosurgical best practices. As telemedicine technology continues to mature and its expanse grows, neurosurgeons’ familiarity with its benefits, limitations, and controversies will best allow for its successful adoption in our field to maximize patient care and outcomes.
Brian Y Hwang, MD, 18D, David Mampre, BS, MD, A Karim Ahmed, MD, Ian Suk, BSc, BMC, William S Anderson, PhD, MD, Amir Manbachi, PhD, Nicholas Theodore, MD
doi : 10.1093/neuros/nyab177
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 372–382
Traumatic spinal cord injury (SCI) is a common and devastating condition. In the absence of effective validated therapies, there is an urgent need for novel methods to achieve injury stabilization, regeneration, and functional restoration in SCI patients. Ultrasound is a versatile platform technology that can provide a foundation for viable diagnostic and therapeutic interventions in SCI. In particular, real-time perfusion and inflammatory biomarker monitoring, focal pharmaceutical delivery, and neuromodulation are capabilities that can be harnessed to advance our knowledge of SCI pathophysiology and to develop novel management and treatment options. Our review suggests that studies that evaluate the benefits and risks of ultrasound in SCI are severely lacking and our understanding of the technology's potential impact remains poorly understood. Although the complex anatomy and physiology of the spine and the spinal cord remain significant challenges, continued technological advances will help the field overcome the current barriers and bring ultrasound to the forefront of SCI research and development.
Jack Henry, BSc, Michael Amoo, MB, MCh, MRCS, Joseph Taylor, MSc, David P O’Brien, MB, MCh, MMedSc, MBA, LLM, FRCSI, FRCS(SN)
doi : 10.1093/neuros/nyab180
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 383–394
Cranioplasty is a ubiquitous neurosurgical procedure consisting of reconstruction of a pre-existing calvarial defect. Many materials are available, including polymethylmethacrylate in hand-moulded (hPMMA) and prefabricated (pPMMA) form, hydroxyapatite (HA), polyetheretherketone (PEEK) and titanium (Ti).
Philip B Ostrov, MS, Ankit I Mehta, MD
doi : 10.1093/neuros/nyab216
Neurosurgery, Volume 89, Issue 3, September 2021, Page E144
Jetan Badhiwala, MD, PhD, Angela Lumba-Brown, MD, Gregory W J Hawryluk, MD, PhD, Jamshid Ghajar, MD, PhD
doi : 10.1093/neuros/nyab181
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 395–405
Traumatic brain injury (TBI) often results in elevations in intracranial pressure (ICP) that are refractory to standard therapies. Several studies have investigated the utility of external lumbar drainage (ELD) in this setting.
Robert E Gross, MD, PhD, Robert S Fisher, MD, PhD, Michael R Sperling, MD, Jonathon E Giftakis, PhD, Paul H Stypulkowski, PhD on behalf of the SANTÉ Study Group
doi : 10.1093/neuros/nyab186
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 406–412
Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) is an effective therapy for patients with drug-resistant focal epilepsy. Best practices for surgical targeting of the ANT can be refined as new information becomes available regarding effective stimulation sites.
Pierre Scheffler, MD, Markus Florian Oertel, MD, Lennart Henning Stieglitz, MD
doi : 10.1093/neuros/nyab176
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 413–419
Normal pressure hydrocephalus (NPH) is frequently treated with ventriculoperitoneal shunt (VPS) surgery. However, VPS implantation can lead to overdrainage and complications such as headaches, hygroma, and subdural hematoma due to a siphon effect in an upright position. Gravitational valves prevent overdrainage through position-dependent adjustment of valve resistance. Flow-regulated valves that increase resistance in presence of high cerebrospinal fluid flow may provide similar protection against overdrainage and present an alternative to gravitational valves.
Heejin Bae, MD, Sang-il Suh, MD, PhD, Won Ki Yoon, MD, PhD, Haewon Roh, MD, Chungyeul Kim, MD, PhD, Taek-Hyun Kwon, MD, PhD
doi : 10.1093/neuros/nyab178
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 420–427
Many physicians consider aneurysmal wall enhancement (AWE) on high resolution-vessel wall imaging (HR-VWI) as an imaging biomarker of unstable unruptured intracranial aneurysms (UIAs).
Nima Alan, MD, Joseph Donohue, BS, Alp Ozpinar, MD, Nitin Agarwal, MD, Adam S Kanter, MD, David O Okonkwo, MD, PhD, D Kojo Hamilton, MD
doi : 10.1093/neuros/nyab179
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 428–434
Patients with Thoracolumbar Injury Classification and Severity (TLICS) score of 4 fall into a gray zone between surgical and conservative management. The integrity of posterior ligamentous complex (PLC) evaluated by magnetic resonance imaging (MRI) contributes to surgical decision-making. Load-sharing classification (LSC) may provide a modifier to further guide decision-making in these patients.
Andrew T Hale, PhD, Oluwatoyin Akinnusotu, BA, Jing He, MS, Janey Wang, MS, Natalie Hibshman, BA, Chevis N Shannon, DrPH, MPH, MBA, Robert P Naftel, MD
doi : 10.1093/neuros/nyab184
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 435–442
Although many clinical risk factors of spastic cerebral palsy (CP) have been identified, the genetic basis of spastic CP is largely unknown. Here, using whole-genome genetic information linked to a deidentified electronic health record (BioVU) with replication in the UK Biobank and FinnGen, we perform the first genome-wide association study (GWAS) for spastic CP.
Kevin K Kumar, MD, PhD, Gerald A Grant, MD
doi : 10.1093/neuros/nyab201
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E145–E146
Ivan Lylyk, MD, Esteban Scrivano, MD, Javier Lundquist, MD, Angel Ferrario, MD, Carlos Bleise, MD, Nicolas Perez, MD, Pedro Nicolas Lylyk, MD, Rene Viso, MD, Rodolfo Nella-Castro, MD, Pedro Lylyk, MD
doi : 10.1093/neuros/nyab183
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 443–449
Prospective studies have established the safety and efficacy of the PipelineTM Embolization Device (PED; Medtronic) for treatment of intracranial aneurysms (IA).
Maria Sheila Guimarães Rocha, MD, PhD, Julian Leticia de Freitas, MD, Carlos Daniel Miranda Costa, MD, Maira Okada de Oliveira, MSc, Paulo Roberto Terzian, MD, João Welberthon Matos Queiroz, MD, Jamana Barbosa Ferraz, BSc, João Fellipe Santos Tatsch, MD, Diogo Coutinho Soriano, PhD, Clement Hamani, MD, PhD, Fabio Godinho, MD, PhD
doi : 10.1093/neuros/nyab195
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 450–459
Gait and balance disturbance are challenging symptoms in advanced Parkinson's disease (PD). Anatomic and clinical data suggest that the fields of Forel may be a potential surgical target to treat these symptoms.
William E Krauss, MD, Elizabeth B Habermann, MPH, PhD, Anshit Goyal, MBBS, MS, Daniel S Ubl, MPH, Mohammed Ali Alvi, MBBS, MS, Daniel C Whipple, MS, Amy E Glasgow, MHA, Halena M Gazelka, MD, Mohamad Bydon, MD
doi : 10.1093/neuros/nyab196
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 460–470
With a dramatic rise in prescription opioid use, it is imperative to review postsurgical prescribing patterns given their contributions to the opioid epidemic.
Seokchun Lim, MD, Victor Chang, MD
doi : 10.1093/neuros/nyab202
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E147–E148
Dean Chou, MD
doi : 10.1093/neuros/nyab211
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E149–E150
Arjun V Pendharkar, MD, Maryam N Shahin, MD, Sohun S Awsare, BA, Allen L Ho, MD, Christine Wachira, DNP, RN, Johnathan Clevinger, MSN, RN, Sveinn Sigurdsson, MS, Yohan Lee, MS, Alicia Wilson, RN, Amy C Lu, MD, Melanie Hayden Gephart, MD
doi : 10.1093/neuros/nyab187
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 471–477
There is a growing body of evidence suggesting not all craniotomy patients require postoperative intensive care.
Adham M Khalafallah, MD, Adrian E Jimenez, BS, Samantha Camp, Melanie A Horowitz, Ian Chiu, David Ryu, Natasha Charewycz, Lauren Vera, Myan Bhoopalam, MS, James Feghali, MD, Mayur Sharma, MD, MCh, Daniel Lubelski, MD, Alan R Cohen, MD, Rafael J Tamargo, MD, Timothy Witham, MD, Judy Huang, MD, Henry Brem, MD, Debraj Mukherjee, MD, MPH
doi : 10.1093/neuros/nyab194
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 478–485
Within the literature, there has been limited research tracking the career trajectories of international medical graduates (IMGs) following residency training.
Krystal L Tomei, MD, MPH
doi : 10.1093/neuros/nyab197
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E151–E152
Alejandro Enriquez-Marulanda, MD, Santiago Gomez-Paz, MD, Mohamed M Salem, MD, MPH, Akashleena Mallick, MD, Rouzbeh Motiei-Langroudi, MD, J E Arle, MD, PhD, Martina Stippler, MD, Efstathios Papavassiliou, MD, Ron L Alterman, MD, Christopher S Ogilvy, MD, Justin M* Moore, MD, PhD, Ajith J Thomas, MD
doi : 10.1093/neuros/nyab192
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 486–495
Middle meningeal artery (MMA) embolization is an emerging minimally invasive endovascular technique for chronic subdural hematoma (cSDH). Currently, limited literature exists on its safety and efficacy compared with conventional treatment (open-surgical-evacuation-only).
Long Di, BS, Christopher P Wang, BS, Ashish H Shah, MD, Daniel G Eichberg, MD, Alexa M Semonche, MD, Alexander D Sanjurjo, BS, Evan M Luther, MD, Walter J Jermakowicz, MD, PhD, Ricardo J Komotar, MD, Michael E Ivan, MBS, MD
doi : 10.1093/neuros/nyab193
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 496–503
Laser interstitial thermal therapy (LITT) is a promising approach for cytoreduction of deep-seated gliomas. However, parameters contributing to treatment success remain unclear.
Nicholas C Field, MD, Julie G Pilitsis, MD, PhD, Alexandra R Paul, MD
doi : 10.1093/neuros/nyab223
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 504–508
Letters of recommendation (LORs) are one of the most important components of the neurosurgical residency application. Studies in other fields and surgical subspecialties have found gender bias.
Krystal L Tomei, MD, MPH, Warren R Selman, MD
doi : 10.1093/neuros/nyab234
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E153–E154
Catherine A Mazzola, MD
doi : 10.1093/neuros/nyab235
Neurosurgery, Volume 89, Issue 3, September 2021, Page E155
Michael Zhang, MD, Elizabeth Tong, MD, Forrest Hamrick, BS, Edward H Lee, PhD, Lydia T Tam, BS, Courtney Pendleton, MD, Brandon W Smith, MD, Nicholas F Hug, BA, Sandip Biswal, MD, Jayne Seekins, DO, Sarah A Mattonen, PhD, Sandy Napel, PhD, Cynthia J Campen, MD, Robert J Spinner, MD, Kristen W Yeom, MD, Thomas J Wilson, MD, Mark A Mahan, MD
doi : 10.1093/neuros/nyab212
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 509–517
Clinicoradiologic differentiation between benign and malignant peripheral nerve sheath tumors (PNSTs) has important management implications.
Vikram C Prabhu, MD, Suguna Pappu, MD, PhD, Ewa Borys, MD, Leighanne Ormston, MS, CGC, Laurie M Lomasney, MD
doi : 10.1093/neuros/nyab224
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E156–E157
Daniel M Fountain, MRCS, Jack Henry, BSc, Susan Honeyman, BMBCh, Paul O’Connor, MBChB, Priya Sekhon, MBBS, Rory J Piper, MRCS, Ellie Edlmann, PhD, Michael Martin, BA, Gemma Whiting, BA, Carole Turner, MSc, Harry Mee, MRCP, Alexis J Joannides, FRCS(SN), Angelos G Kolias, FRCS(SN), Peter J Hutchinson, FMedSci, UK Cranial Reconstruction Registry (UKCRR) Collaborative , British Neurosurgical Trainee Research Collaborative (BNTRC)
doi : 10.1093/neuros/nyab220
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 518–526
There are many questions that remain unanswered regarding outcomes following cranioplasty including the timing of cranioplasty following craniectomy as well as the material used.
Joseph S Bell, MD, PhD, T J Florence, MD, PhD, H Westley Phillips, MD, Kunal Patel, MD, Nicholas J Macaluso, BS, Paulina G Villanueva, BS, Priyanka K Naik, BS, Won Kim, MD
doi : 10.1093/neuros/nyab221
Neurosurgery, Volume 89, Issue 3, September 2021, Pages 527–536
Venous thromboembolism (VTE) represents a rare but preventable postoperative complication. Unfractionated heparin (UH) and low-molecular-weight heparin (LMWH) are used to prevent VTE, but comparative studies of their safety and efficacy in the neurosurgical context are limited.
Mohamed Macki, MD, MPH, Victor Chang, MD
doi : 10.1093/neuros/nyab230
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E158–E159
Mohamed Abouelleil, MD, Leah Lyons, PA-C, Andres Restrepo, MD, Justin Singer, MD
doi : 10.1093/neuros/nyab190
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E160–E161
Visish M Srinivasan, MD, Michael T Lawton, MD
doi : 10.1093/neuros/nyab225
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E162–E164
Timothy C Gooldy, MD, Laura A Snyder, MD
doi : 10.1093/neuros/nyab227
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E165–E166
Ding-Jun Hao, MD, Jia-Nan Zhang, MD
doi : 10.1093/neuros/nyab189
Neurosurgery, Volume 89, Issue 3, September 2021, Page E167
Naci Balak, MD
doi : 10.1093/neuros/nyab198
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E168–E169
Joseph R Linzey, MD, MS, Aditya S Pandey, MD
doi : 10.1093/neuros/nyab200
Neurosurgery, Volume 89, Issue 3, September 2021, Page E170
Andre E Boyke, MS, Nathan A Shlobin, BA, Vaishnavi Sharma, BS, Donald K E Detchou, BA, Myron Rolle, MD
doi : 10.1093/neuros/nyab199
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E171–E172
Sirinkaanta Pongprasert, PhD
doi : 10.1093/neuros/nyab205
Neurosurgery, Volume 89, Issue 3, September 2021, Page E173
David P Bray, MD, Joseph W Quillin, MD, Robert H Press, MD, Yilin Yang, BS, Zhengjia Chen, PhD, Bree R Eaton, MD, Jeffrey J Olson, MD
doi : 10.1093/neuros/nyab204
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E174–E175
Michael R Chicoine, MD, Albert H Kim, MD, PhD
doi : 10.1093/neuros/nyab207
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E176–E177
Laura Ganau, Gianfranco K I Ligarotti, MD, Lara Prisco, MD, MSc, Mario Ganau, MD, PhD, MBA, FEBNS
doi : 10.1093/neuros/nyab188
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E178–E179
Julio C Furlan, MD, LLB, MBA, MSc, PhD, FRCPC, Charles H Tator, MD, PhD, FRCSC
doi : 10.1093/neuros/nyab191
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E180–E181
Zeferino Demartini, Jr, MD, Adriano Keijiro Maeda, MD, MSc, Gelson Luis Koppe, MD, L A M Gatto, MD, MSc, Adriane Cardoso-Demartini, MD, PhD
doi : 10.1093/neuros/nyab206
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E182–E183
Anthony Larson, BS, Megha Tollefson, MD, Waleed Brinjikji, MD
doi : 10.1093/neuros/nyab208
Neurosurgery, Volume 89, Issue 3, September 2021, Page E184
Syed Faraz Kazim, MD, PhD, Christian A Bowers, MD, Robert A Lloyd, BS, Chad D Cole, MD, MS, Meic H Schmidt, MD, MBA
doi : 10.1093/neuros/nyab210
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E185–E186
Mervyn Jun Rui Lim, MBBS, MPH
doi : 10.1093/neuros/nyab214
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E187–E188
Philip C De Witt Hamer, MD, PhD, Martin Klein, PhD, Shawn L Hervey-Jumper, MD, Jeffrey S Wefel, PhD, Mitchel S Berger, MD
doi : 10.1093/neuros/nyab218
Neurosurgery, Volume 89, Issue 3, September 2021, Page E189
Grazia Menna, MD, Ismail Zaed, MD, Giuseppe Maria Della Pepa, MD
doi : 10.1093/neuros/nyab217
Neurosurgery, Volume 89, Issue 3, September 2021, Page E190
Borislav D Kitov, MD, PhD, Atanas N Davarski, MD, PhD, Tanya T Kitova, MD, PhD, DMSc, Kristina P Kilova, MEng, MHM, PhD
doi : 10.1093/neuros/nyab215
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E191–E192
Daniel G Eichberg, MD, Gregory W Basil, MD, Long Di, BS, Ashish H Shah, MD, Evan M Luther, MD, Victor M Lu, MD, PhD, Maggy Perez-Dickens, MBA, Ricardo J Komotar, MD, Allan D Levi, MD, PhD, Michael E Ivan, MD, MBS
doi : 10.1093/neuros/nyab226
Neurosurgery, Volume 89, Issue 3, September 2021, Page E193
Sandra Marcela Mass-Ramirez, MS, Ivan David Lozada-Martínez, MS, Amit Agrawal, MCh, Luis Rafael Moscote-Salazar, MD, Pedro Jose Cabarcas-Sabbag, MD, William Florez-Perdomo, MD
doi : 10.1093/neuros/nyab213
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E194–E195
Natalie Limoges, DO, Scott L Zuckerman, MD, MPH, Lola B Chambless, MD, Deborah L Benzil, MD, Aurora Cruz, MD, MBA, Susan Durham, MD, MS
doi : 10.1093/neuros/nyab219
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E196–E197
Andrew I Yang, MD, MS, Opeyemi O Alabi, PhD, Frederick L Hitti, MD, PhD, Lenora Henry, MS, Ryan Clanton, PhD, Gordon H Baltuch, MD, PhD
doi : 10.1093/neuros/nyab233
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E198–E200
Chidinma M Wilson, BA, BS, Nolan J Brown, BS, Donald K E Detchou, BA
doi : 10.1093/neuros/nyab232
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E201–E202
Raúl Martínez-Fernández, MD, PhD, Jorge U Máñez-Miró, MD, Rafael Rodríguez-Rojas, PhD, Marta del Álamo, MD, José A Obeso, MD, PhD
doi : 10.1093/neuros/nyab236
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E203–E204
Bennet Omalu, MD, MBA, MPH, Jennifer Hammers, DO
doi : 10.1093/neuros/nyab231
Neurosurgery, Volume 89, Issue 3, September 2021, Pages E205–E206
doi : 10.1093/neuros/nyab270
Neurosurgery, Volume 89, Issue 3, September 2021, Page 537
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟